Advertisement

Topics

Dr. Reddy's Laboratories Announces the Launch of Clofarabine Injection in the U.S. Market

06:19 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar® (clofarabine) Injection in the United States ...

Other Sources for this Article

INVESTOR RELATIONS
SAUNAK SAVLA, +91-40-49002135
saunaks@drreddys.com
or
MEDIA RELATIONS
CALVIN PRINTER, +91-40- 49002121
calvinprinter@drreddys.com

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's Laboratories Announces the Launch of Clofarabine Injection in the U.S. Market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...